Tasigna - 0078-0526-51 - (nilotinib)

Alphabetical Index


Drug Information of Tasigna

Product NDC: 0078-0526
Proprietary Name: Tasigna
Non Proprietary Name: nilotinib
Active Ingredient(s): 200    mg/1 & nbsp;   nilotinib
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Tasigna

Product NDC: 0078-0526
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022068
Marketing Category: NDA
Start Marketing Date: 20071029

Package Information of Tasigna

Package NDC: 0078-0526-51
Package Description: 28 CAPSULE in 1 BLISTER PACK (0078-0526-51)

NDC Information of Tasigna

NDC Code 0078-0526-51
Proprietary Name Tasigna
Package Description 28 CAPSULE in 1 BLISTER PACK (0078-0526-51)
Product NDC 0078-0526
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name nilotinib
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20071029
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name NILOTINIB
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]

Complete Information of Tasigna


General Information